David B Meya

Biographic Data

ID1743916
NAMEDavid B Meya
GIVEN NAMESDavid B
FAMILY NAMEMeya
SIGNATUREMEYA D B
AFFILIATIONSInfectious Diseases Institute
ORCID0000-0002-8854-0321
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS1
WORKS AS AUTHOR8
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2026
H-INDEX1

  • Meningitis diagnosis, treatment, and outcomes in rural, northern Uganda

    Open AccessAbigail Link, Mark Okwir et al.ARTICLEPLOS Global Public Health2026

    Meningitis affects over 2.5 million people worldwide, primarily within resource-limited regions of the meningitis belt of Africa. In 2017, we implemented a cryptococcal meningitis (CM) diagnosis and treatment program (CM-DTP) designed to improve CM outcomes. In 2021, a meningitis diagnosis and treatment program (MEN-DTP) began to include all etiologies of meningitis to assess the impact of expanded diagnosis and treatment of meningitis. We conduc…

  • Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda

    Open AccessDavid S Lawrence, Agnes Ssali et al.ARTICLESSM - Qualitative Research in…2023

    HIV-associated cryptococcal meningitis remains a key driver of AIDS-related mortality. Mortality is twice as high in those who present later to care and with severe symptoms such as confusion. We embedded a qualitative methods study within a randomised controlled trial in Gaborone, Botswana and Kampala, Uganda with the aim of understanding pathways to care. We conducted in-depth interviews with trial participants and surrogate decision makers and…

  • Clinical characteristics and morbidity among hospitalized adults with advanced HIV disease in Uganda during ‘test and treat’ era

    Open AccessLillian Tugume, Fred C Semitala et al.ARTICLEPLOS Global Public Health2023

    Nearly four decades after the first case of AIDS was described, the global number of AIDS-related deaths has steadily declined but falls short of the elimination targets, especially in sub-Saharan Africa. Despite interventions to promote early HIV diagnosis and treatment, hospitalization and mortality related to advanced HIV disease (AHD) remains a significant public health problem in Uganda. We assessed the HIV treatment history and causes of ho…

  • Factors influencing ART adherence, acceptability and potential use of “Call for life IVR tool” among young people in rural Uganda

    Open AccessAgnes Bwanika Naggirinya, Peter Waiswa et al.ARTICLESocial Sciences & Humanities Open2022

    Young people (15–24 years) living with HIV have lower viral load suppression rates compared to older adults. The main causes of poor viral load suppression are; non-compliance to clinic visits, lack of HIV & ART knowledge, inconsistent swallowing of pills, and poor pill adherence. Persistent viremia is associated with the development of drug resistance and low immunity, which increases the risk of opportunistic infections and death. The World Hea…

  • Impact of a Cryptococcal meningitis diagnosis and treatment program at Lira Regional Referral Hospital in rural, Northern Uganda

    Open AccessAbigail Link, Mark Okwir et al.ARTICLEPLOS Global Public Health2022

    In rural areas of sub-Saharan Africa, infrastructure and resources for treatment of cryptococcal meningitis (CM) are often lacking. We introduced a CM diagnosis and treatment program (CM-DTP) at Lira Regional Referral Hospital (LRRH) in rural Uganda to determine if implementing high-quality standard of care protocols would improve outcomes. Information extracted from hospital charts and clinical record forms at LRRH were used to compare diagnoses…

  • Barriers to HIV care in Uganda and implications for universal test-and-treat

    Sarah M Lofgren, Sharon Tsui et al.ARTICLEAIDS Care2022

    Achieving universal HIV test-and-treat will require targeted interventions for those with worse outcomes, including advanced HIV. We conducted qualitative, semi-structured interviews with healthcare workers (HCWs) and people living with HIV (PLWH) at 5 HIV clinics in Kampala, Uganda, to understand barriers to care. PLWH enrolled started/restarted on HIV treatment ≤3 months prior. PLWH were grouped as 1) "ART-experienced" or those restarted therap…

  • Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women

    Open AccessSarah M Lofgren, Sharon Tsui et al.ARTICLEAIDS and Behavior2022

  • Decision making in a clinical trial for a life-threatening illness

    Open AccessDavid S Lawrence, Agnes Ssali et al.ARTICLESocial Science & Medicine2022Cited by: 1References: 40

    Potential participants for clinical trials which aim to define treatments for life-threatening conditions are often extremely unwell. When exploring why individuals participate in clinical trials one common observation is a misplaced expectation of personal benefit - a therapeutic misconception. The care offered in some clinical trials is of a higher standard than is routinely available and this has led to criticism around the freedom of choice t…